Central Admixture Pharmacy Services, Inc. recalls neostigmine 5 mg/5mL (1mg/mL) Syringe, Rx only, This drug was repacked by CAPS, Inc., 2200 South 43rd Avenue, Pheonix,
Recalled August 9, 2023 · FDA recall D-0982-2023 · Central Admixture Pharmacy Services
Hazard
Lack of assurance of sterility. Validation data for decontamination cycles is lacking. · FDA Class II
Units
6,468 Syringes
Sold at
Nationwide in the USA
Description
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Product
neostigmine 5 mg/5mL (1mg/mL) Syringe, Rx only, This drug was repacked by CAPS, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6065-1
Manufacturer(s)
Central Admixture Pharmacy Services, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →